Elaine Zaharis-Nikas to succeed William Scapell as Head of Fixed Income and Preferred Securities following over 20 years of partnership NEW YORK, Jan. 17, 2024 /PRNewswire/ — Cohen & Steers, Inc. (NYSE: CNS) announced today that William Scapell, Head of Fixed Income and Preferred Securities, will retire from the firm and investment management on August… Continue reading Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024
Category: Newswire
Kodiak Technologies and Roush combine capabilities to power the next generation of Industrial Snow Blowers
DETROIT, Jan. 17, 2024 /PRNewswire/ — Kodiak Technologies is leveraging Roush’s suite of mobility services – including design, engineering, prototyping, and testing to power Kodiak’s next generation of Industrial Snow Blowers. Development of Kodiak’s first hybrid models are planned for delivery in 2025. To meet demand for more environmentally sustainable snow removal equipment, pre-orders will… Continue reading Kodiak Technologies and Roush combine capabilities to power the next generation of Industrial Snow Blowers
Sentinel Capital Partners to Acquire Insignia Portfolio Company Market Performance Group
WALNUT CREEK, Calif., Jan. 17, 2024 /PRNewswire/ — Insignia Capital Group is pleased to announce it has completed the sale of portfolio company Market Performance Group (“MPG” or the “Company”) to affiliates of Sentinel Capital Partners (“Sentinel”). Founded in 2002, Market Performance Group is a highly regarded omnichannel commerce agency providing a full suite of… Continue reading Sentinel Capital Partners to Acquire Insignia Portfolio Company Market Performance Group
Innovative Portfolios CIO Dave Gilreath Challenges FPA of Greater Indiana
Topic: Is Fear Costing Your Clients Millions? (Your Fear, Not Their Fear) INDIANAPOLIS, Jan. 17, 2024 /PRNewswire/ — Innovative Portfolios CIO Dave Gilreath, CFP® challenged members of the Financial Planning Association (FPA) of Greater Indiana during their November meeting about whether Advisors’ fear of volatility might be negatively impacting their clients’ investing outcomes. Continue Reading… Continue reading Innovative Portfolios CIO Dave Gilreath Challenges FPA of Greater Indiana
Government Initiatives and Policies for Waste Management Practices to Steer Garbage Bag Market Past US$ 14,602.3 Million by 2034
Future Market Insights, Inc. (FMI) forecasts a robust future for the garbage bag market, fueled by rising demand for convenient and hygienic waste disposal solutions. While traditional PE bags remain dominant, biodegradability and sustainability are emerging as key growth drivers. Explore full report for insights & stakeholder opportunities. NEWARK, Del., Jan. 17, 2024 /PRNewswire/ —… Continue reading Government Initiatives and Policies for Waste Management Practices to Steer Garbage Bag Market Past US$ 14,602.3 Million by 2034
Non-Alcoholic Steatohepatitis Treatment Drug Market In Japan is Expected to Showcase Impressive Growth by 2032 | DelveInsight
The total market size of non-alcoholic steatohepatitis (NASH) is anticipated to upsurge during the forecast period due to the expected entry of emerging therapies that include MGL-3196 (Resmetirom), Lanifibranor/ IVA337, Efruxifermin, and others. LAS VEGAS, Jan. 17, 2024 /PRNewswire/ — DelveInsight’s Non-Alcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, non-alcoholic steatohepatitis… Continue reading Non-Alcoholic Steatohepatitis Treatment Drug Market In Japan is Expected to Showcase Impressive Growth by 2032 | DelveInsight
Quantum Announces Update on Plan to Regain Nasdaq Compliance and Delayed Form 10-Q Filing
SAN JOSE, Calif., Jan. 17, 2024 /PRNewswire/ — Quantum Corporation (Nasdaq: QMCO) (“Quantum” or the “Company”) announced today that in accordance with Nasdaq Listing Rules, the Company has submitted its plan to regain compliance on January 16, 2024. If the plan is accepted by the Nasdaq Stock Market LLC (“Nasdaq”), the Company expects to be granted… Continue reading Quantum Announces Update on Plan to Regain Nasdaq Compliance and Delayed Form 10-Q Filing
Haivision Announces Results for the Three Months and Full Year Ended October 31, 2023
Haivision continues to increase gross margins, improves operational efficiency while delivering 11.3% year over year revenue growth Haivision announces TSX acceptance of Normal Course Issuer Bid MONTREAL, Jan. 17, 2024 /PRNewswire/ – Haivision Systems Inc. (“Haivision” or the “Company“) (TSX: HAI), a leading global provider of mission critical, real-time video networking and visual collaboration solutions, today… Continue reading Haivision Announces Results for the Three Months and Full Year Ended October 31, 2023
Palmer Square Capital BDC Inc. Prices Initial Public Offering
MISSION WOODS, Kan., Jan. 17, 2024 /PRNewswire/ — Palmer Square Capital BDC Inc. (“Palmer Square“), an externally managed business development company, today announced that it priced its initial public offering of 5,450,000 shares of its common stock at $16.45 per share, for anticipated gross proceeds of approximately $89.7 million. Palmer Square’s shares of common stock… Continue reading Palmer Square Capital BDC Inc. Prices Initial Public Offering
Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies – Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
DelveInsight’s analysis estimate that the beta-thalassemia market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of novel therapies during the forecasted period (2023–2032). LAS VEGAS, Jan. 17, 2024 /PRNewswire/ — DelveInsight’s Beta-thalassemia Market Insights report includes a comprehensive understanding of current treatment practices, beta-thalassemia emerging drugs, market share of… Continue reading Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies – Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics